KOBI MOSELEY: Open Payments
NPI 1700360823 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,909 in 102 payments from 12 companies in 2025. Trend: 2023 $1,458 · 2024 $2,013 · 2025 $1,909
Food & beverage: $1,810Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $777 |
| Amgen Inc. | 14 | $224 |
| GENZYME CORPORATION | 8 | $203 |
| Janssen Biotech, Inc. | 6 | $201 |
| UCB, Inc. | 9 | $167 |
| E.R. Squibb & Sons, L.L.C. | 5 | $106 |
| Genentech USA, Inc. | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| PFIZER INC. | 2 | $46 |
| Aurinia Pharma U.S., Inc. | 2 | $32 |
Products named: RINVOQ, KEVZARA, TREMFYA, SKYRIZI, Bimzelx, TAVNEOS, ORENCIA, KRYSTEXXA.
Industry payments across MI — which companies pay providers there.
